{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36846498", "DateCompleted": {"Year": "2023", "Month": "02", "Day": "28"}, "DateRevised": {"Year": "2023", "Month": "02", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "02", "Day": "15"}], "Language": ["eng"], "ELocationID": ["8074413", "10.1155/2023/8074413"], "Journal": {"ISSN": "1742-1241", "JournalIssue": {"Volume": "2023", "PubDate": {"Year": "2023"}}, "Title": "International journal of clinical practice", "ISOAbbreviation": "Int J Clin Pract"}, "ArticleTitle": "Attitudes and Practices of the Use of Third-Generation Cephalosporins among Medical Doctors Practicing in Cameroon.", "Pagination": {"StartPage": "8074413", "MedlinePgn": "8074413"}, "Abstract": {"AbstractText": ["Third-generation cephalosporins (3GC) are among the most prescribed antibiotics worldwide. Antibiotic resistance, usually due to misuse and overuse, is a feared complication of public health concern. However, there are limited data in Cameroon concerning the knowledge and use of 3GC in our health services. The aim of this study was to assess the knowledge and use of 3GC among medical doctors in Cameroon and to generate baseline information for a wider scale research and policy implementation.", "This study was a cross-sectional study conducted among medical doctors practicing in Cameroon in general. Convenience sampling was used and the data were collected from both the online questionnaire and the review of files of patients admitted and discharged within the month of April 2021 and analysed with the use of IBM SPSS v25. <i>Results and Discussion</i>. A total of 52 respondents from the online questionnaire and 31 reviewed files were retained. Of the respondents, 27% were female and 73% were male. The mean age and years of experience were 29.6\u2009\u00b1\u20092.9 and 3.6\u2009\u00b1\u20092.1 years, respectively. Only 32.7% had correct knowledge of the number of generations of cephalosporins, and 48.1% had knowledge of the antimicrobial target. All medical doctors (MD) identified ceftriaxone as a 3GC, and it was the most commonly prescribed 3GC (71%). Most of the MD considered 3GC to be an efficient antibiotic. Just over half (54.7%) knew the correct posology of ceftriaxone. Only 17% and 9.4% knew the right posology for cefotaxime and ceftazidime, respectively, for the management of early-onset neonatal infection (EONNI). The misuse of 3GC was mostly attributed to nurses, MD, and poor institutional policies.", "There is average knowledge on 3GC among MD, with ceftriaxone being the most widely known and prescribed. Misuse is common among nurses and doctors. Poor institutional policies and limited laboratory capacities are to be blamed."], "CopyrightInformation": "Copyright \u00a9 2023 Elisabeth Zeuko'o Menkem et al."}, "AuthorList": [{"Identifier": ["0000-0002-0878-5020"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical Sciences, Faculty of Health Sciences, University of Buea, Buea, Cameroon."}, {"Identifier": [], "Affiliation": "Antimicrobial and Biocontrol Agents Unit, Laboratory for Phytobiochemistry and Medicinal Plants Studies, University of Yaounde 1, Yaound\u00e9, Cameroon."}], "LastName": "Menkem", "ForeName": "Elisabeth Zeuko'o", "Initials": "EZ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Studies, Faculty of Health Sciences, University of Buea, Buea, Cameroon."}], "LastName": "Labo Nanfah", "ForeName": "Astride", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Studies, Faculty of Health Sciences, University of Buea, Buea, Cameroon."}], "LastName": "Takang", "ForeName": "Tiku", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Studies, Faculty of Health Sciences, University of Buea, Buea, Cameroon."}], "LastName": "Ryan Awah", "ForeName": "Lesley", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Public Health, Faculty of Health Sciences, University of Buea, Buea, Cameroon."}], "LastName": "Awah Achua", "ForeName": "Kenneth", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Studies, Faculty of Health Sciences, University of Buea, Buea, Cameroon."}], "LastName": "Ekane Akume", "ForeName": "Stanley", "Initials": "S"}, {"Identifier": ["0000-0002-3147-364X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Antimicrobial and Biocontrol Agents Unit, Laboratory for Phytobiochemistry and Medicinal Plants Studies, University of Yaounde 1, Yaound\u00e9, Cameroon."}], "LastName": "Fekam Boyom", "ForeName": "Fabrice", "Initials": "F"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "India", "MedlineTA": "Int J Clin Pract", "NlmUniqueID": "9712381", "ISSNLinking": "1368-5031"}, "ChemicalList": [{"RegistryNumber": "75J73V1629", "NameOfSubstance": "Ceftriaxone"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Bacterial Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Cephalosporins"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Infant, Newborn"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Ceftriaxone"}, {"QualifierName": [], "DescriptorName": "Cameroon"}, {"QualifierName": [], "DescriptorName": "Cross-Sectional Studies"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Anti-Bacterial Agents"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Cephalosporins"}, {"QualifierName": [], "DescriptorName": "Attitude"}], "CoiStatement": "The authors declare that they have no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ndihokubwayo J. B., Yahaya A. A., Desta A. T., et al. Antimicrobial resistance in the African Region: issues, challenges and actions proposed. African Health Monitor . 2013;16:27\u201330."}, {"Citation": "Pandey N., Cascella M. Beta Lactam Antibiotics . Treasure Island, FL, USA: StatPearls Publishing; 2021.", "ArticleIdList": ["31424895"]}, {"Citation": "El-Shaboury S. R., Saleh G. A., Mohamed F. A., Rageh A. H. Analysis of cephalosporin antibiotics. Journal of Pharmaceutical and Biomedical Analysis . 2007;45(1):1\u201319. doi: 10.1016/j.jpba.2007.06.002.", "ArticleIdList": ["10.1016/j.jpba.2007.06.002", "17689910"]}, {"Citation": "Talebi Bezmin Abadi A., Rizvanov A. A., Haertl\u00e9 T., Blatt N. L. World Health Organization report: current crisis of antibiotic resistance. Bio Nano Science . 2019;9(4):778\u2013788. doi: 10.1007/s12668-019-00658-4.", "ArticleIdList": ["10.1007/s12668-019-00658-4"]}, {"Citation": "Dodds D. R. Antibiotic resistance: a current epilogue. Biochemical Pharmacology . 2017;134:139\u2013146. doi: 10.1016/j.bcp.2016.12.005.", "ArticleIdList": ["10.1016/j.bcp.2016.12.005", "27956111"]}, {"Citation": "Sarkar P., Yarlagadda V., Ghosh C., Haldar J. A review on cell wall synthesis inhibitors with an emphasis on glycopeptide antibiotics. Medchemcomm . 2017;8(3):516\u2013533. doi: 10.1039/c6md00585c.", "ArticleIdList": ["10.1039/c6md00585c", "PMC6072328", "30108769"]}, {"Citation": "Klein N. C., Cunha B. A. Third-generation cephalosporins. Medical Clinics of North America . 1995;79(4):705\u2013719. doi: 10.1016/s0025-7125(16)30034-7.", "ArticleIdList": ["10.1016/s0025-7125(16)30034-7", "7791418"]}, {"Citation": "Klein N. C., Cunha B. A. The selection and use of cephalosporins: a review. Advances in Therapy . 1995;12(2):83\u2013101.", "ArticleIdList": ["10150326"]}, {"Citation": "Pichichero M. E. Cephalosporins Can Be Prescribed Safely for Penicillin-Allergic Patients. Journal of Family Practice . 2006;55(2):106\u201312.", "ArticleIdList": ["16451776"]}, {"Citation": "Adu A., Armour C. L. Drug utilisation review (DUR) of the third generation cephalosporins. Drugs . 1995;50(3):423\u2013439. doi: 10.2165/00003495-199550030-00002.", "ArticleIdList": ["10.2165/00003495-199550030-00002", "8521766"]}, {"Citation": "Sileshi A., Tenna A., Feyissa M., Shibeshi W. Evaluation of ceftriaxone utilization in medical and emergency wards of Tikur Anbessa specialized hospital: a prospective cross-sectional study. BMC Pharmacol Toxicol . 2016;17(1):p. 7. doi: 10.1186/s40360-016-0057-x.", "ArticleIdList": ["10.1186/s40360-016-0057-x", "PMC4759859", "26891697"]}, {"Citation": "Pereira L. M. P., Phillips M., Ramlal H., Teemul K., Prabhakar P. Third generation cephalosporin use in a tertiary hospital in Port of Spain, Trinidad: need for an antibiotic policy. BMC Infectious Diseases . 2004;4(1):1\u20137.", "ArticleIdList": ["PMC545064", "15601475"]}, {"Citation": "Usman M., Jamal S., Tabassum S., Zafran M. Length of stay of patients in a tertiary care hospital. Gomal Journal of Medical Sciences . 2011;9(1):18\u201321."}, {"Citation": "Wang X., Wu D., Xuan Z., Wang W., Zhou X. The influence of a ban on outpatient intravenous antibiotic therapy among the secondary and tertiary hospitals in China. BMC Public Health . 2020;20(1):p. 1794. doi: 10.1186/s12889-020-09948-z.", "ArticleIdList": ["10.1186/s12889-020-09948-z", "PMC7690204", "33239002"]}, {"Citation": "Ayele A. A., Gebresillassie B. M., Erku D. A., et al. Prospective Evaluation of Ceftriaxone Use in Medical and Emergency Wards of Gondar university Referral Hospital, Ethiopia. Pharmacology research and perspectives . 2018;6(1)", "ArticleIdList": ["PMC5817827", "29417764"]}, {"Citation": "Kwatra S., Taneja G., Nasa N. Alternative routes of drug administration- transdermal, pulmonary and parenteral. Indo Global Journal of Pharmaceutical Sciences . 2012;02(04):409\u2013426. doi: 10.35652/igjps.2012.47.", "ArticleIdList": ["10.35652/igjps.2012.47"]}, {"Citation": "Raj G., Raveendran R. Introduction to Basics of Pharmacology and Toxicology Volume 1: General and Molecular Pharmacology: Principles of Drug Action . Gateway East, Singapore: Springer Nature Singapore Pte Ltd; 2019."}, {"Citation": "Talevi A., Quiroga P. ADME Processes in Pharmaceutical Sciences: Dosage, Design, and Pharmacotherapy Success . Switzerland Europe: Springer; 2018."}, {"Citation": "Thampithak A., Chaisiri K., Siangsuebchart O., Phengjaturat K., Aonjumras W., Hemapanpairoa J. Prescription pattern of intravenous fosfomycin in a provincial hospital in Thailand. Infect Chemother . 2022;54(4):699\u2013710. doi: 10.3947/ic.2022.0098.", "ArticleIdList": ["10.3947/ic.2022.0098", "PMC9840959", "36450288"]}, {"Citation": "Alemkere G., Tenna A., Engidawork E. Antibiotic use practice and predictors of hospital outcome among patients with systemic bacterial infection: identifying targets for antibiotic and health care resource stewardship. PLoS One . 2019;14(2) doi: 10.1371/journal.pone.0212661.e0212661", "ArticleIdList": ["10.1371/journal.pone.0212661", "PMC6386277", "30794660"]}, {"Citation": "Dechasa M., Chelkeba L., Jorise A., Sefera B., Melaku T. Antibiotics use evaluation among hospitalized adult patients at Jimma Medical Center, southwestern Ethiopia: the way to pave for antimicrobial stewardship. Journal of Pharmaceutical Policy and Practice . 2022;15(1):p. 84. doi: 10.1186/s40545-022-00490-4.", "ArticleIdList": ["10.1186/s40545-022-00490-4", "PMC9673421", "36397142"]}, {"Citation": "Kayambankadzanja R. K., Lihaka M., Barratt-Due A., et al. The use of antibiotics in the intensive care unit of a tertiary hospital in Malawi. BMC Infectious Diseases . 2020;20(1):p. 776. doi: 10.1186/s12879-020-05505-6.", "ArticleIdList": ["10.1186/s12879-020-05505-6", "PMC7574463", "33076857"]}, {"Citation": "Gebremichael T. G., Gebreyesus H. H., Gebremariam A. Assessment of the appropriateness of ceftazidime use in a tertiary teaching hospital, northern Ethiopia. Drug, Healthcare and Patient Safety . 2019;11:115\u2013123. doi: 10.2147/dhps.s226505.", "ArticleIdList": ["10.2147/dhps.s226505", "PMC6930387", "31908541"]}, {"Citation": "Jenkins T. C., Stella S. A., Cervantes L., et al. Targets for antibiotic and health care resource stewardship in inpatient community-acquired pneumonia: a comparison of management practices with national guideline recommendations. Infection . 2013;41(1):135\u2013144. doi: 10.1007/s15010-012-0362-2.", "ArticleIdList": ["10.1007/s15010-012-0362-2", "PMC3567260", "23160837"]}, {"Citation": "Mauldin P. D., Salgado C. D., Hansen I. S., Durup D. T., Bosso J. A. Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria. Antimicrobial Agents and Chemotherapy . 2010;54(1):109\u2013115. doi: 10.1128/AAC.01041-09.", "ArticleIdList": ["10.1128/AAC.01041-09", "PMC2798544", "19841152"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "10", "Day": "21"}, {"Year": "2023", "Month": "1", "Day": "23"}, {"Year": "2023", "Month": "1", "Day": "25"}, {"Year": "2023", "Month": "2", "Day": "27", "Hour": "5", "Minute": "55"}, {"Year": "2023", "Month": "2", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "3", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "15"}], "PublicationStatus": "epublish", "ArticleIdList": ["36846498", "PMC9946740", "10.1155/2023/8074413"]}}], "PubmedBookArticle": []}